Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 3
Review
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,305 | Dovepress* | 9,355+ | 1,955 | 11,310 | |
| PubMed Central* | 2,950 | 1,138 | 4,088 | ||
| Totals | 12,305 | 3,093 | 15,398 | ||
| *Since 21 September 2016 | |||||
View citations on PubMed Central and Google Scholar